CANF

Can-Fite BioPharma

10 hedge funds and large institutions have $1.77M invested in Can-Fite BioPharma in 2016 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 0 increasing their positions, 4 reducing their positions, and 3 closing their positions.

Holders
10
Holders Change
+1
Holders Change %
+11.11%
% of All Funds
0.27%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
Reduced
4
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
TAM
1
Taylor Asset Management
Ontario, Canada
$1.54M 553,100 -14,900 -3%
MC
2
Menta Capital
California
$106K 38,100 -700 -2%
VKH
3
Virtu KCG Holdings
New York
$44K 15,606 -2,220 -12%
ARTA
4
A.R.T. Advisors
New York
$35K 12,693 +12,693 New
Jane Street
5
Jane Street
New York
$30K 10,591 -26,460 -71%
Group One Trading
6
Group One Trading
Illinois
$6K 2,048
MFS
7
MSI Financial Services
Massachusetts
$3K 1,000
TRCT
8
Tower Research Capital (TRC)
New York
$1K 200 +200 New
Morgan Stanley
9
Morgan Stanley
New York
-241,586 Closed
Creative Planning
10
Creative Planning
Kansas
-4,900 Closed
IA
11
IFP Advisors
Florida
-1,500 Closed
Walleye Trading
12
Walleye Trading
New York
$0 23 +23 New
Citigroup
13
Citigroup
New York
$0 147 +147 New